Answers are grounded in this paper and cite their sources.
Nano-biomaterials have become essential tools in biomedical and healthcare applications. To fully harness their potential, it is crucial to develop synthesis methods that are non-toxic, biocompatible, and environmentally friendly. This review highlights recent advancements in nano-biomaterials that address significant challenges such as bone regeneration, implant-associated infections, drug delivery, wound healing, and theranostics. Inorganic nanomaterials demonstrate notable biocompatibility and osteoinductive properties, making them suitable for bone and dental applications. Additionally, nanoparticle-reinforced hydrogels improve drug delivery and tissue regeneration by mimicking the extracellular matrix. Antibacterial surface coatings help to prevent implant-related infections while promoting tissue integration. Stimuli-responsive nanomaterials allow for controlled drug release in response to internal or external signals. Furthermore, CRISPR-Cas9-based nanocarriers enable precise gene editing with minimal off-target effects. Smart nanomaterials are also enhancing theranostic platforms and innovative tissue repair strategies. This review emphasizes the transformative role of multifunctional nano-biomaterials in shaping next-generation biomedical therapies.
No takes yet. Share an insight, caveat, or question.
Mullick et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: